These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17515399)

  • 1. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
    Qian J; Xie J; Hong S; Yang J; Zhang L; Han X; Wang M; Zhan F; Shaughnessy JD; Epstein J; Kwak LW; Yi Q
    Blood; 2007 Sep; 110(5):1587-94. PubMed ID: 17515399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
    Lu C; Meng S; Jin Y; Zhang W; Li Z; Wang F; Wang-Johanning F; Wei Y; Liu H; Tu H; Su D; He A; Cao X; Zhou F
    Br J Haematol; 2017 Aug; 178(3):413-426. PubMed ID: 28508448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
    Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
    J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.
    Qian J; Zheng Y; Zheng C; Wang L; Qin H; Hong S; Li H; Lu Y; He J; Yang J; Neelapu S; Kwak LW; Hou J; Yi Q
    Blood; 2012 Jan; 119(1):161-9. PubMed ID: 22049519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
    Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
    Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma.
    Li R; Zheng C; Wang Q; Bi E; Yang M; Hou J; Fu W; Yi Q; Qian J
    Haematologica; 2021 Mar; 106(3):838-846. PubMed ID: 32079700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
    Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
    Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.
    Jalili A; Ozaki S; Hara T; Shibata H; Hashimoto T; Abe M; Nishioka Y; Matsumoto T
    Blood; 2005 Nov; 106(10):3538-45. PubMed ID: 16037388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
    Anderson LD; Cook DR; Yamamoto TN; Berger C; Maloney DG; Riddell SR
    Cancer Immunol Immunother; 2011 Jul; 60(7):985-97. PubMed ID: 21461886
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Khalaf WS; Garg M; Mohamed YS; Stover CM; Browning MJ
    Front Immunol; 2019; 10():1792. PubMed ID: 31428094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
    Belle S; Han F; Condomines M; Christensen O; Witzens-Harig M; Kasper B; Kleist C; Terness P; Moos M; Cremer F; Hose D; Ho AD; Goldschmidt H; Klein B; Hundemer M
    Eur J Haematol; 2008 Jul; 81(1):26-35. PubMed ID: 18363871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
    Siegel S; Wagner A; Friedrichs B; Wendeler A; Wendel L; Kabelitz D; Steinmann J; Barsoum A; Coggin J; Rohrer J; Dreger P; Schmitz N; Zeis M
    J Immunol; 2006 Jun; 176(11):6935-44. PubMed ID: 16709854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma.
    Goodyear OC; Pearce H; Pratt G; Moss P
    Cancer Immunol Immunother; 2011 Dec; 60(12):1751-61. PubMed ID: 21785964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
    Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
    Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.
    Li R; Qian J; Zhang W; Fu W; Du J; Jiang H; Zhang H; Zhang C; Xi H; Yi Q; Hou J
    Br J Haematol; 2014 Sep; 166(5):690-701. PubMed ID: 24824351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.
    Mayr C; Bund D; Schlee M; Bamberger M; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2006 Jan; 34(1):44-53. PubMed ID: 16413390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.
    Bae J; Song W; Smith R; Daley J; Tai YT; Anderson KC; Munshi NC
    Br J Haematol; 2012 Jun; 157(6):687-701. PubMed ID: 22533610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
    Schmidt SM; Schag K; Müller MR; Weinschenk T; Appel S; Schoor O; Weck MM; Grünebach F; Kanz L; Stevanovic S; Rammensee HG; Brossart P
    Cancer Res; 2004 Feb; 64(3):1164-70. PubMed ID: 14871853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination.
    Kather A; Ferrara A; Nonn M; Schinz M; Nieland J; Schneider A; Dürst M; Kaufmann AM
    Int J Cancer; 2003 Apr; 104(3):345-53. PubMed ID: 12569558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.